Evoke Pharma ( NASDAQ: EVOK ) on Monday announced the promotion of Mark Kowieski, formerly VP of Finance, to the role of CFO in May. Mark brings a wealth of financial and public accounting experience and a deep understanding of Evoke Pharma’s operations to the role, which are instrumental in enhancing our operational efficiency and driving excellence, the company added. The company will report full results for sales in the second quarter in August.
EVOK +4.026% premarket to $0.4909 Source: Press Release More on Evoke Pharma Seeking Alpha’s Quant Rating on Evoke Pharma Historical earnings data for Evoke Pharma Financial information for Evoke Pharma.
